心通医疗-B(02160)上涨20.79%，报1.22元/股

金融界03-06

3月6日，心通医疗-B(02160)盘中上涨20.79%，截至13:51，报1.22元/股，成交2516.96万元。心通医疗是一家中国领先的医疗器械企业，主要从事结构性心脏病领域的经导管和手术解决方案的研发和商业化，产品包括VitaFlow系列经导管主动脉瓣植入(TAVI)产品、经导管二尖瓣治疗产品、经导管三尖瓣治疗产品、外科瓣膜产品和手术配件等。目前，该公司的产品已进入中国近500家核心医院，并...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2517188327?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-03-06 13:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2517188327","market":"us","top_or_hot":-1,"title":"心通医疗-B(02160)上涨20.79%，报1.22元/股","media":"金融界","content":"<div>\n<p>3月6日，心通医疗-B(02160)盘中上涨20.79%，截至13:51，报1.22元/股，成交2516.96万元。心通医疗是一家中国领先的医疗器械企业，主要从事结构性心脏病领域的经导管和手术解决方案的研发和商业化，产品包括VitaFlow系列经导管主动脉瓣植入(TAVI)产品、经导管二尖瓣治疗产品、经导管三尖瓣治疗产品、外科瓣膜产品和手术配件等。目前，该公司的产品已进入中国近500家核心医院，并...</p>\n\n<a href=\"https://finance.jrj.com.cn/2025/03/06135148557357.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>心通医疗-B(02160)上涨20.79%，报1.22元/股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n心通医疗-B(02160)上涨20.79%，报1.22元/股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-03-06 13:51 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.jrj.com.cn/2025/03/06135148557357.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>3月6日，心通医疗-B(02160)盘中上涨20.79%，截至13:51，报1.22元/股，成交2516.96万元。心通医疗是一家中国领先的医疗器械企业，主要从事结构性心脏病领域的经导管和手术解决方案的研发和商业化，产品包括VitaFlow系列经导管主动脉瓣植入(TAVI)产品、经导管二尖瓣治疗产品、经导管三尖瓣治疗产品、外科瓣膜产品和手术配件等。目前，该公司的产品已进入中国近500家核心医院，并...</p>\n\n<a href=\"https://finance.jrj.com.cn/2025/03/06135148557357.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"https://finance.jrj.com.cn/2025/03/06135148557357.shtml","article_id":"2517188327","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2517188327","pubTimestamp":1741240306,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"3月6日，心通医疗-B盘中上涨20.79%，截至13:51，报1.22元/股，成交2516.96万元。心通医疗是一家中国领先的医疗器械企业，主要从事结构性心脏病领域的经导管和手术解决方案的研发和商业化，产品包括VitaFlow系列经导管主动脉瓣植入产品、经导管二尖瓣治疗产品、经导管三尖瓣治疗产品、外科瓣膜产品和手术配件等。截至2024年中报，心通医疗-B营业总收入2.23亿元、净利润-5646.1万元。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1583":"高瓴概念","BK1100":"医疗保健设备","BK1574":"生物医药B类股","02160":"心通医疗-B"},"translate_title":"Xintong Medical-B (02160) rose 20.79% to 1.22 yuan per share","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02160":1},"content_text":"3月6日，心通医疗-B(02160)盘中上涨20.79%，截至13:51，报1.22元/股，成交2516.96万元。心通医疗是一家中国领先的医疗器械企业，主要从事结构性心脏病领域的经导管和手术解决方案的研发和商业化，产品包括VitaFlow系列经导管主动脉瓣植入(TAVI)产品、经导管二尖瓣治疗产品、经导管三尖瓣治疗产品、外科瓣膜产品和手术配件等。目前，该公司的产品已进入中国近500家核心医院，并在阿根廷、泰国、哥伦比亚、巴西等4个国家销售，同时，公司正在全力推进核心产品获得欧盟CE认证，并积极布局印度、韩国、俄罗斯、墨西哥、智利等海外市场。截至2024年中报，心通医疗-B营业总收入2.23亿元、净利润-5646.1万元。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2517188327"}